OBJECTIVES OF THE COURSE

The aim of the meeting is to provide a comprehensive update based on evidence on NMIBC’s current diagnostic, treatment and follow-up strategies, highlighting the importance of an integrated, sustainable and personalised approach.

The following topics will be discussed:

– Epidemiology and risk factors of NMIBC in the European context

– From macroematuria to diagnosis: initial clinical and diagnostic path

– The role of imaging and its evolution

– The pathological anatomy of urothelial carcinoma and the criticalities of in situ carcinoma

– The high quality TURB as an essential standard

– NMIBC's economic and organisational burden in health systems

– Strategies to control the progression and role of early cystectomy

– Immunotherapy and the prospects of BCG, with focus on maintenance

– Systemic and targeted therapies in clinical trials

– Follow-up models: balance between effective surveillance and risk of overtreatment

– Styles of life, patient support and contribution of associations